FDA Inspection 926688 — Mentholatum (China) Pharmaceuticals Co., Ltd.

Mentholatum (China) Pharmaceuticals Co., Ltd. — FEI 3000188423

The FDA completed an inspection of Mentholatum (China) Pharmaceuticals Co., Ltd. on Apr 10, 2015 in Zhongshan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 10, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Zhongshan (China)

Citations

IDCFRDescription
113321 CFR 211.25(a)GMP Training Frequency
189021 CFR 211.165(e)Test methods
191721 CFR 211.166(a)(1)Sample size - test intervals
434221 CFR 211.142(b)Storage under appropriate conditions

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.